Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group.

× No keyword cloud information.

30 in total

1. In vitro activities of clarithromycin and azithromycin against clinical isolates of Mycobacterium avium-M. intracellulare.

Authors: L Steele-Moore; K Stark; W J Holloway
Journal: Antimicrob Agents Chemother Date: 1999-06 Impact factor: 5.191

2. Immune Reconstitution and the Consequences for Opportunistic Infection Treatment and Prevention.

Authors:
Journal: Curr Infect Dis Rep Date: 1999-04 Impact factor: 3.725

3. Analysis of a population-based Pneumocystis carinii pneumonia index as an outcome measure of access and quality of care for the treatment of HIV disease.

Authors: Peter S Arno; Marc N Gourevitch; Ernest Drucker; Jing Fang; Clara Goldberg; Margaret Memmott; Karen Bonuck; Nandini Deb; Ellie Schoenbaum
Journal: Am J Public Health Date: 2002-03 Impact factor: 9.308

4. Levels of proinflammatory cytokines in plasma after pneumoccoccal immunization in human immunodeficiency virus type 1-infected patients.

Authors: H Valdez; S Purvis; R Asaad; I Valerio; B E Sha; A L Landay; M M Lederman
Journal: Clin Diagn Lab Immunol Date: 1999-05

5. Recommendations for screening and prevention of tuberculosis in patients with HIV and for screening for HIV in patients with tuberculosis and their contacts.

Authors: Richard Long; Stan Houston; Earl Hershfield
Journal: CMAJ Date: 2003-10-14 Impact factor: 8.262

Review 6. Prevention of infection due to Pneumocystis carinii.

Authors: J A Fishman
Journal: Antimicrob Agents Chemother Date: 1998-05 Impact factor: 5.191

7. Executive summary: 2013 update of the guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children.

Authors: George K Siberry; Mark J Abzug; Sharon Nachman
Journal: Pediatr Infect Dis J Date: 2013-12 Impact factor: 2.129

8. Molecular characterization of the cytochrome b gene and in vitro atovaquone susceptibility of Plasmodium falciparum isolates from Kenya.

Authors: Luicer A Ingasia; Hoseah M Akala; Mabel O Imbuga; Benjamin H Opot; Fredrick L Eyase; Jacob D Johnson; Wallace D Bulimo; Edwin Kamau
Journal: Antimicrob Agents Chemother Date: 2015-01-12 Impact factor: 5.191

Review 9. Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.

Authors: Kuan-Yeh Lee; Mao-Song Tsai; Kuang-Che Kuo; Jen-Chih Tsai; Hsin-Yun Sun; Aristine C Cheng; Sui-Yuan Chang; Chen-Hsiang Lee; Chien-Ching Hung
Journal: Hum Vaccin Immunother Date: 2014 Impact factor: 3.452

10. Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy.

Authors: Martin Luther Koanga Mogtomo; Louise Carole Gouabe Malieugoue; Carolle Djiepgang; Michel Wankam; Andre Moune; Annie Ngono Ngane
Journal: Infect Agent Cancer Date: 2009-06-03 Impact factor: 2.965